Improving brain activity measurement in everyday settings using wearable technology
Official title: Expanding Inclusion of All Subjects for Ultra-High Density Wearable fNIRS in the Everyday World
Funded at Boston University (Charles River Campus) · NIH-10950582 · Data updated 2026-11-12
This study is testing a new wearable device that can track brain activity while you go about your daily life, helping us understand how your brain works during movement and social interactions, and it’s designed to work well for everyone, no matter their hair type or skin tone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University (Charles River Campus) NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | September 1, 2024 |
| Project end | July 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $422,619 |
| NIH project number | 1UG3EB036035-01 |
| Project ID | NIH-10950582 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals of diverse backgrounds and characteristics, particularly those interested in how brain function relates to movement and cognition.
✕Less likely to help
Patients with conditions that severely limit movement or cognitive function may not benefit from this research.
What this research studies
This research focuses on developing advanced wearable technology that can continuously measure brain activity in real-world environments. By utilizing ultra-high density functional Near Infrared Spectroscopy (fNIRS), the study aims to link brain function with human movement, perception, and social interactions in real time. The approach addresses challenges related to hair characteristics and skin tone that can affect measurement accuracy, ensuring that all individuals can be included in the research. This technology could provide valuable insights into both healthy brain function and the causes of breakdowns in cognitive and communicative abilities.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and treatment of cognitive and movement disorders by providing real-time insights into brain function.
How similar studies have gone: Previous research has shown promise in using wearable fNIRS technology, but this approach aims to significantly enhance measurement capabilities and inclusivity.
Where this research is happening
-
Boston University (Charles River Campus)
Boston, United States Active
Researchers
- Principal investigator: Boas, David a — Boston University (Charles River Campus)
- Study coordinator: Boas, David a
Related research
Other NIH-funded projects on the same topics.
-
How Arousal Changes How We See the World
This grant studies how moments of alertness or mood changes alter how the brain processes what we see.
-
NGF Metabolism as a biomarker for cognitive decline in familial Alzheimer's disease
Researchers are studying whether patterns in nerve growth factor pathways in blood and CSF can signal early, preclinical stages of Alzheimer's in people with genetic risk.
-
NGF metabolism as an early biomarker for cognitive decline in familial Alzheimer's disease
This project tests whether NGF pathway proteins in blood and CSF can signal early, preclinical changes in people with familial Alzheimer’s disease.
-
Ultra-High Density wearable brain monitoring in real life
Aims to make advanced wearable brain sensors that work in daily life to track brain activity alongside movement, perception, and communication.
-
A new method to image brain activity noninvasively using speckle contrast spectroscopy
A new, noninvasive imaging technique called speckle contrast optical spectroscopy (SCOS) could help measure brain blood flow in people, including those with brain injuries or neurodegenerative conditions.
-
NGF Metabolic Dysfunction as a Marker of Cognitive Decline in Autosomal Dominant Alzheimer's Disease
This project looks at nerve growth factor pathways in people with a genetic form of Alzheimer's to see if blood and spinal fluid markers can identify early brain changes before symptoms appear.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.